OPIANT PHARMACEUTICALS INC - COM (OPNT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q2 2023

Type / Class
Equity / COM
Symbol
OPNT
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$5,394 0
2023 Q1 0 $0 -$43,236,521 0
2022 Q4 2,132,344 $43,241,915 +$11,831,067 $20.28 37
2022 Q3 1,804,973 $19,401,935 -$644,609 $10.75 32
2022 Q2 1,863,755 $22,346,158 +$1,538,645 $11.99 32
2022 Q1 1,556,667 $33,339,856 +$2,150,828 $21.42 39
2021 Q4 1,416,078 $47,618,053 +$4,922,996 $33.63 41
2021 Q3 1,269,546 $32,675,633 +$10,083,818 $25.74 33
2021 Q2 877,730 $11,762,755 -$439,624 $13.38 26
2021 Q1 913,764 $9,700,877 +$101,331 $10.61 30
2020 Q4 903,550 $7,259,929 +$251,969 $8.03 28
2020 Q3 948,058 $7,090,956 +$882,833 $7.48 27
2020 Q2 821,768 $7,419,398 -$2,440,136 $9.02 27
2020 Q1 1,067,451 $10,225,909 +$1,467,008 $9.58 29
2019 Q4 914,828 $13,173,392 +$709,637 $14.40 27
2019 Q3 879,849 $13,293,997 +$1,664,860 $15.06 24
2019 Q2 770,357 $10,205,323 -$196,928 $13.25 15
2019 Q1 787,117 $10,326,202 +$164,989 $13.12 22
2018 Q4 768,291 $11,104,308 +$1,097,964 $14.45 22
2018 Q3 652,300 $11,650,610 +$9,250,414 $17.86 25
2018 Q2 134,369 $1,921,346 +$272,976 $14.29 14
2018 Q1 112,521 $2,159,124 +$104,964 $19.23 13
2017 Q4 97,728 $2,245,000 +$1,269,849 $22.92 16
2017 Q3 34,046 $1,252,000 +$1,252,000 $36.73 10
2016 Q2 0 $0 -$1,000 0
2016 Q1 112 $1,000 $8.93 1